Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carroll

Showing results (1391-1400 of 1,449) with videos related to

Pageof 145
Sort By:
Nature Communications|May 18, 2023
Giardia hinders growth by disrupting nutrient metabolism independent of inflammatory enteropathyNatasa Giallourou, Jason Arnold, Elizabeth T Rogawski McQuade, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Journal of Experimental Medicine|June 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.
Cancer Cell|April 20, 2005
Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitorsMark R Lackner, Rachel M Kindt, Pamela M Carroll, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Drug and Alcohol Dependence|June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adultsKevin M Gray, Susan C Sonne, Erin A McClure, et al.
The Medical Journal of Australia|July 31, 2015
A new era in the treatment of multiple sclerosisSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Occupational and Environmental Medicine|March 25, 2006
Validation of short term recall of mobile phone use for the Interphone studyM Vrijheid, E Cardis, B K Armstrong, et al.
Pageof 145

Showing results (1391-1400 of 1,449) with videos related to

Sort By:
Pageof 145
Nature Communications|May 18, 2023
Giardia hinders growth by disrupting nutrient metabolism independent of inflammatory enteropathyNatasa Giallourou, Jason Arnold, Elizabeth T Rogawski McQuade, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Journal of Experimental Medicine|June 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical modelsParwiz Abrahimi, Jonathan F Khan, Alyssa Duren-Lubanski, et al.
Cancer Cell|April 20, 2005
Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitorsMark R Lackner, Rachel M Kindt, Pamela M Carroll, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Drug and Alcohol Dependence|June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adultsKevin M Gray, Susan C Sonne, Erin A McClure, et al.
The Medical Journal of Australia|July 31, 2015
A new era in the treatment of multiple sclerosisSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Occupational and Environmental Medicine|March 25, 2006
Validation of short term recall of mobile phone use for the Interphone studyM Vrijheid, E Cardis, B K Armstrong, et al.
Pageof 145